One local biotech fund manager said he is not interested in Prima given it has to undertake a three-year clinical trial for C-Vac. “Also its ovarian cancer treatment might not be relevant in a few years with newer and better treatments coming to market.”
How are they going to get to market with new treatments before they do preclincal, ph i,ii & iii trials...before Prima....Magic Wand!
All good with CVac but phii results need a big +ve to win over this market!
DYOR!
today's fin review, page-2
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.030(9.68%) |
Mkt cap ! $494.5M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 35.0¢ | 32.0¢ | $4.857M | 14.38M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 142807 | 2 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |